H35.711
Central serous chorioretinopathy, right eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Central serous chorioretinopathy (CSC) is an eye condition characterized by the buildup of fluid underneath the retina, which is the light-sensitive tissue at the back of the eye. When this fluid accumulates in the central part of the retina, it can cause visual disturbances. The specific code H35.711 refers to CSC affecting the right eye. Though it can affect individuals of various ages, it is most commonly seen in young to middle-aged adults, particularly in those experiencing high stress or taking corticosteroid medications.
Causes & Symptoms
Clinical Causes: Stress and emotional pressure Use of corticosteroid medications, including pills, inhalers, or topical treatments Certain sleep disorders, such as stress-related disruptions Type A personality traits, which involve competitiveness and urgency Hypertension (high blood pressure) Existing eye conditions or retinal abnormalities Genetic factors that may predispose individuals to retinal issues
Key Symptoms: Blurred or distorted vision, especially in the central visual field A dark or gray spot in the center of your vision A sensation of a shadow or curtain over part of your visual field Straight lines appearing crooked or bent (metamorphopsia) Color changes or decreased color sensitivity in the affected eye Usually sudden onset with symptoms often resolving spontaneously within a few months
Diagnostic & Treatment
Diagnosis Path: Diagnosing CSC involves comprehensive eye examinations, including a detailed patient history and specialized imaging tests. These tests help confirm the presence of fluid beneath the retina and distinguish CSC from other retinal or ocular conditions. Common diagnostic tools include: - Optical Coherence Tomography (OCT): Provides high-resolution cross-sectional images of the retina to detect subretinal fluid - Fluorescein Angiography: Uses a dye injected into the bloodstream to visualize blood flow in retinal vessels and identify leaks - Indocyanine Green Angiography: Similar to fluorescein angiography but provides better visualization of deeper choroidal vessels Prompt diagnosis is essential for monitoring and managing the condition effectively.
Treatment Protocols: Most cases of CSC resolve on their own within three to four months without specific treatment. However, healthcare providers may recommend various approaches depending on the severity and duration of symptoms: - Observation: Regular monitoring for spontaneous resolution - Laser Photocoagulation: Targeted laser treatment to seal leaking blood vessels in persistent cases - Photodynamic Therapy (PDT): Uses a light-activated drug to reduce choroidal blood flow and minimize fluid leakage - Medications: Some doctors may prescribe medications to help reduce fluid accumulation or address underlying factors such as stress - Managing risk factors: Strategies include stress management techniques and adjusting medications if corticosteroids are implicated Early consultation with an eye specialist is important to determine the most appropriate approach based on individual circumstances.
Clinical Advice & FAQs
Billing Guidance
Is H35.711 a billable ICD-10 code?
Yes, H35.711 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.711?
Clinical documentation must specify the nature of Central serous chorioretinopathy, right eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
